Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Hair loss can cause low self-esteem, anxiety, and depression in men.

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

New effective scar treatments are urgently needed due to the current options' limited success.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Current treatments for alopecia show no significant long-term benefits.

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Low-level laser therapy might help hair growth, but more research is needed.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.